Rapid reduction of severe hypertension with minoxidil. 1980

J H Bauer, and M A Alpert

Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p.o.). Systemic blood pressure, heart rate, and cardiac output were measured prior to and hourly following the addition of minoxidil to the regimen of propranolol and furosemide. One hour following the addition of minoxidil, systemic blood pressure decreased from 204/126 to 186/114 mm Hg (mean systolic/mean diastolic blood pressure). Four hours after minoxidil administration, systemic blood pressure was 175/105 mm Hg. Four of the 5 subjects exhibited diastolic blood pressures greater than 100 mm Hg at 4 hr and were given a booster dose of minoxidil (5--20 mg). Systemic blood pressure subsequently decreased to 153/92 mm Hg at 8 hr and to 142/86 mm Hg at 12 hr following the initial dose of minoxidil. The reduction of systemic blood pressure was achieved without significant change in heart rate or cardiac output. These data indicate that stepped-care therapy utilizing a diuretic, a beta-blocking agent, and minoxidil produces prompt, significant, and sustained reduction of systemic blood pressure in patients with severe, potentially life-threatening hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008914 Minoxidil A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371) Loniten,Regaine,Rogaine,U 10858
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

J H Bauer, and M A Alpert
October 1986, Singapore medical journal,
J H Bauer, and M A Alpert
July 1975, JAMA,
J H Bauer, and M A Alpert
October 1975, Israel journal of medical sciences,
J H Bauer, and M A Alpert
January 1978, Acta medica Scandinavica,
J H Bauer, and M A Alpert
January 1981, Drug and therapeutics bulletin,
J H Bauer, and M A Alpert
October 1983, Australian and New Zealand journal of medicine,
J H Bauer, and M A Alpert
November 1978, European journal of clinical pharmacology,
J H Bauer, and M A Alpert
January 1975, Current therapeutic research, clinical and experimental,
J H Bauer, and M A Alpert
May 1977, The Journal of pediatrics,
J H Bauer, and M A Alpert
November 1977, Canadian Medical Association journal,
Copied contents to your clipboard!